Lee Schacter
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Oncology top 5%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
Papers in
-
- Cancer therapeutics and mechanisms 6
- Glutathione Transferases and Polymorphisms 4
- Oncology 16
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 4
- Co-authors
- Lawrence H. Einhorn (2 shared papers)Gary H. Lyman (1 shared paper)Howard S. Höchster (1 shared paper)K. S. Sridhar (1 shared paper)Lawrence T. Goodnough (1 shared paper)W. Andy Knight (1 shared paper)L H Einhorn (1 shared paper)Joanne Mortimer (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Biochemical and Biophysical Research Communications (3 papers)Journal of Thoracic Oncology (2 papers)Experimental Cell Research (2 papers)Cancer (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Lee Schacter
45 papers receiving 2.2k citations
Lee Schacter's Hit Papers
Peers
Comparison fields: 5 of 115
- Otorhinolaryngology 344
- Oncology 832
- Genetics 235
- Hematology 203
- Epidemiology 348
Countries citing papers authored by Lee Schacter
This map shows the geographic impact of Lee Schacter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Schacter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Schacter more than expected).
Fields of papers citing papers by Lee Schacter
This network shows the impact of papers produced by Lee Schacter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Schacter. The network helps show where Lee Schacter may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Schacter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. Hit paper breakdown → | 1992 | 497 |
| 2 | 1992 | 435 | |
| 3 | 1991 | 216 | |
| 4 | 1988 | 140 | |
| 5 | 1998 | 91 | |
| 6 | Etoposide phosphate: what, why, where, and how? | 1996 | 88 |
| 7 | 1990 | 52 | |
| 8 | 1989 | 52 | |
| 9 | 1976 | 52 | |
| 10 | 1988 | 47 | |
| 11 | 2006 | 39 | |
| 12 | 1972 | 39 | |
| 13 | 2009 | 38 | |
| 14 | 1970 | 38 | |
| 15 | 1985 | 36 | |
| 16 | 2006 | 31 | |
| 17 | 1980 | 29 | |
| 18 | 1982 | 27 | |
| 19 | 1996 | 26 | |
| 20 | 2000 | 26 |
About Lee Schacter
Lee Schacter is a scholar working on Molecular Biology, Oncology, Genetics, Epidemiology and Pathology and Forensic Medicine, having authored 45 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (9 papers), Cancer therapeutics and mechanisms (6 papers), Glutathione Transferases and Polymorphisms (4 papers), Cancer Treatment and Pharmacology (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (344 citations), Oncology (832 citations), Genetics (235 citations), Hematology (203 citations) and Epidemiology (348 citations). Lee Schacter has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Lawrence H. Einhorn, Gary H. Lyman, Howard S. Höchster, K. S. Sridhar, Lawrence T. Goodnough, W. Andy Knight, L H Einhorn, Joanne Mortimer, Charlotte Jacobs and E Vélez-García. Their work appears in journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications, Journal of Thoracic Oncology, Experimental Cell Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.